The U.S. Elections and Health Policy: Health Equity in the 2024 U.S. Presidential Election
The next U.S. president will inherit multiple epidemics with inequitably distributed effects. Kamala Harris and Donald Trump are likely to take divergent policy approaches...
RENOIR Trial — RSVpreF Vaccine Efficacy over Two Seasons
Respiratory syncytial virus remains a serious cause of illness in older persons. In this follow-up report of the RENOIR trial, efficacy of the RSVpreF...
Therapy for Hodgkin’s Lymphoma — Can It Get Any Better?
The approach to Hodgkin’s lymphoma treatment has emphasized the use of chemotherapy agents and radiation therapy to kill cancer cells. In the past, radiation...
Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma
In patients with advanced-stage Hodgkin’s lymphoma, nivolumab added to chemotherapy resulted in greater 2-year progression-free survival than the addition of brentuximab vedotin to chemotherapy.
The...
Cryoglobulinemia — One Name for Two Diseases
Cryoglobulinemia is caused by the precipitation of immunoglobulin molecules when plasma or blood cools to 4°C. The term is routinely applied to two distinct...
